Integra NeuroSciences Reports Positive Clinical Results from a Five-Year Study of the OSVII Smart Valve for the Treatment of Hydrocephalus
August 05, 2003 07:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., August 5, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the results of a five-year prospective, multicenter study of the OSVII(R) Smart...
Integra LifeSciences Reports Record Operating Earnings and Revenues for the Second Quarter 2003
July 31, 2003 06:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, NJ, July 31, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $5.4 million, or $0.18 per share, for the second quarter of 2003, as...
Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
July 22, 2003 12:17 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., July 22, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Thursday, July 31 to...
Court Upholds Integra LifeSciences Patents; Finding of Infringement by Merck KGaA upheld; Case Remanded For New Damages Calculation
June 09, 2003 06:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., June 9, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States Court of Appeals for the Federal Circuit, ruling in the...
Integra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System
May 01, 2003 16:19 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., May 1, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the release of a new and improved Hermetic Plus(TM) external ventricular drainage...
Positive Results of DuraGen Dural Graft Matrix Clinical Experience Involving 169 Patients Presented at AANS 2003 Annual Meeting in San Diego
April 30, 2003 12:38 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 29, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Dr. Peter D. LeRoux of the University of Pennsylvania Neurosurgery and...
Investigators Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at AANS 2003 Annual Meeting In San Diego
April 29, 2003 16:08 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 29, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that members of the Department of Neurosurgery and Surgery of the University of...
Integra LifeSciences Announces 1,000th Implant of NeuraGen Nerve Guide for Peripheral Nerve Repair
April 29, 2003 16:03 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 29, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported that more than 1,000 NeuraGen(TM) Nerve Guides have been implanted in patients...
Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003
April 25, 2003 07:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 25, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $5.4 million, or $0.18 per share, for the first quarter of 2003,...
Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes
April 11, 2003 08:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 11, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that the initial purchasers of its 2.5% Contingent Convertible Subordinated Notes due...